Business Context and Reporting Period
This Form 8-K Current Report was filed by IMMUNIC, INC. on April 20, 2020, covering events occurring on April 15 and April 17, 2020. The filing primarily addresses significant changes in executive leadership and the execution of material definitive agreements regarding employment and separation.
Key Financial Metrics
This filing does not contain standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on personnel changes and associated contractual obligations.
Material Changes and Agreements
Departure of Former CFO
Sanjay S. Patel resigned as Chief Financial Officer effective April 17, 2020. He entered into a Confidential Severance Agreement with the following terms:
- Severance Pay: Six months of continued base salary totaling $165,000.
- Equity Acceleration: Accelerated vesting of 19,973 stock options.
- Benefits: COBRA reimbursement for twelve months and unpaid compensation through the termination date.
- Conditions: The agreement is subject to a seven-day revocation period and becomes effective on the eighth day following execution.
Appointment of Executive Chairman
Duane Nash, MD, JD, MBA, entered into an Executive Chairman Agreement effective April 17, 2020, following board approval on April 15, 2020.
- Compensation: Monthly base salary of $25,417 (inclusive of director fees).
- Benefits: Health, dental, life, disability insurance, and 401(k) participation.
- Term: Initial term ending October 15, 2020, extendable by mutual consent.
- Termination: "At-will" employment; either party may terminate with 30 days' notice.
Internal Promotion
Glenn Whaley, previously Principal Accounting Officer and Controller, was promoted to Vice President Finance, Principal Financial and Accounting Officer. He will assume day-to-day financial management responsibilities and report directly to CEO Daniel Vitt.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or management commentary on business operations. The primary risk disclosed relates to the transition of financial leadership and the immediate cash outflow associated with the severance package for the departing CFO.
Key Facts for Investor Verification
- Verify the total immediate cash liability of $165,000 for the former CFO's severance.
- Confirm the impact of the 19,973 accelerated stock options on the company's share count and dilution.
- Monitor the transition of financial controls under the newly promoted VP Finance, Glenn Whaley.
- Review the attached Exhibits 10.1 and 10.2 for full legal terms of the separation and employment agreements.